Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles

Open Access

Original Article

J App Pharm Sci. 2017; 7(2): 207-216

Toxicological studies and assessment of pharmacological activities of Abrus precatorius L. (Fabaceae) ethanolic leaves extract in the management of pain, psychiatric and neurological conditions An in-vivo study

Sumanta Mondal, Debjit Ghosh, Krishna Chaitanya Anusuri, Seru Ganapaty.

Abrus precatorius L. is an important medicinal plant belonging to family Fabaceae. The present study was conducted to perform pre-clinical safety evaluation and study the pharmacological effects of the ethanolic leaves extract of A. precatorius in management of pain, psychiatric and neurological conditions. Acute toxicity was performed to study the general behavioural pattern of mice after treatment with the test extract (single doses of 100, 1000, 1500 mg/kg, body weight) and sub-acute toxicity studies were performed to study the toxic effects of the test extract (500 mg/kg, per os for 14 days) on different biochemical and haematological parameters, body and organ weight and histopathology of liver and kidney. The toxicological evaluation of A. precatorius ethanolic leaves extract revealed that it has a reasonable safety profile. Analgesic and neuropharmacological effects like muscle relaxant, locomotor, anti-epileptic and anti-depressant activities were also studied on different animal models. The result showed that ethanolic leaves extract of A. precatorius at the doses of 300 and 500 mg/kg, p.o. possesses significant analgesic and neuropharmacological activities. Thus the present study shows that A. precatorius possesses a reasonable safety profile and can be used in the management of pain, psychiatric and neurological conditions.

Key words: Abrus precatorius, Analgesic, Diazepam, Neurological disorders, Toxicity

Similar Articles

Advancing Our Understanding of Brain Disorders: Research Using Postmortem Brain Tissue.
Curtis MA, Vedam-Mai V
Methods in molecular biology (Clifton, N.J.). 2022; 2389(): 201-208

Effects of selenium-containing compounds on Cu/Zn-induced neuronal cell death and potential application as therapeutic agents for neurological diseases.
Tanaka KI, Shimoda M, Kawahara M
Neural regeneration research. 2022; 17(2): 311-312

Challenges in developing therapeutic strategies for mild neonatal encephalopathy.
McDouall A, Wassink G, Bennet L, Gunn AJ, Davidson JO
Neural regeneration research. 2022; 17(2): 277-282

Leukoaraiosis is associated with clinical symptom severity, poor neurological function prognosis and stroke recurrence in mild intracerebral hemorrhage: a prospective multi-center cohort study.
Xu TQ, Lin WZ, Feng YL, Shen FX, Chen J, Wu WW, Zhu XD, Gu L, Fu Y
Neural regeneration research. 2022; 17(4): 819-823

Microglia regulation of synaptic plasticity and learning and memory.
Cornell J, Salinas S, Huang HY, Zhou M
Neural regeneration research. 2022; 17(4): 705-716

Full-text options

Latest Statistics about COVID-19
• pubstat.org

Add your Article(s) to Indexes
• citeindex.org

Covid-19 Trends and Statistics
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.

ScopeMed Web Sites